Riyadh — Mubasher: Nahdi Medical Company reported a net profit of SAR 450.90 million for the first half (H1) of 2026, representing an 8.65% decrease from the SAR 493.60 million recorded in H1-25.
The annual decline in profitability occurred despite a 5.93% increase in total revenues which reached SAR 5.47 billion compared to SAR 5.16 billion in January-June 2025, according to a bourse filing.
For the second quarter (Q2) of 2026, Nahdi Medical posted a 9.73% decrease in net profit to SAR 215.20 million.
The company attributed the lower quarterly earnings to rising operating expenses linked to ongoing investments in healthcare services, e-commerce platforms, and digital transformation.
Quarterly revenue, meanwhile grew 5.80% year-on-year (YoY) to SAR 2.67 billion, supported by a 36.9% surge in the healthcare segment and a 24.6% increase in regional operations.
Nahdi Medical elaborated that its retail network expanded to 1,217 pharmacies, while its healthcare division grew to 14 clinics.
E-commerce contribution to total revenue rose to 30.2% during the period, up from 24.8% a year earlier.
Earnings per share (ES) stood at SAR 3.47 for the six-month period ended on 30 June 2026.
It is worth noting that the company’s board of directors approved a cash dividend distribution of SAR 2.60 per share for H1-26 at a total of SAR 338 million.
In Q1-26, Nahdi Medical posted net profits worth SAR 235.70 million and revenue of SAR 2.79 billion.
